Displaying items by tag: gregory fleming james cystic fibrosis research center
After a national search, Brian R. Davis, Ph.D., has been named the director of the UAB Gregory Fleming James Cystic Fibrosis Research Center (CFRC), effective July 1.
A two-drug combination therapy for cystic fibrosis is shown to be effective. Triple combination therapy is close behind.
Tagged under
A UAB physician will co-chair a steering committee of global cystic fibrosis experts and clinical trial investigators to support the design, conduct and execution of the triple combination pivotal study program.
Tagged under
UAB and UMass researchers have uncovered a new mechanistic understanding of potential treatment for genetic disorders.
Tagged under
Cystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.
Tagged under
David M. Bedwell, Ph.D., professor in the Department of Microbiology and associate director of the Gregory Fleming James Cystic Fibrosis Center, has been named the interim chair of the UAB Department of Biochemistry and Molecular Genetics.
Tagged under
The Cystic Fibrosis Foundation recognizes UAB’s Adult CF Program with Quality Care Award.
Tagged under
Steven M. Rowe, M.D., MSPH, has been named director of the Gregory Fleming James Cystic Fibrosis Research Center in the UAB School of Medicine, effective Aug. 1.
Tagged under